Since our study had a relatively low number of patients and had a cross-sectional design, further longitudinal studies are needed to evaluate if reduction of serum HMGB1 levels might be important in CV risk management in GPA. This evidence concerns the gene HMGB1 and granulomatosis with polyangiitis.